Clinical Study Results

Research Sponsor: AstraZeneca AB

Treatments Studied:
- Budesonide and formoterol fumarate inhalation aerosol
- Budesonide and formoterol fumarate dry powder inhaler

Study Purpose: This study was done to learn how budesonide and formoterol fumarate inhalation aerosol works in participants with chronic obstructive pulmonary disease.

Protocol Number: D5980C00023

Thank you!
Thank you for taking part in the clinical study for these 2 study treatments:
- Budesonide and formoterol fumarate inhalation aerosol, also known as budesonide and formoterol fumarate metered dose inhaler or "BFF MDI"
- Budesonide and formoterol fumarate dry powder inhaler, also known as "BFF DPI"

You and all of the participants helped researchers learn more about BFF MDI and BFF DPI to help people with long-standing, severe chronic obstructive pulmonary disease, also called COPD.

AstraZeneca AB sponsored this study and believes it is important to share the results of the study with you and the public. An independent non-profit organization called CISCRP helped prepare this summary of the study results for you. We hope it helps you understand and feel proud of your important role in medical research.

If you participated in the study and have questions about the results, please speak with the study doctor or staff at your study site.